Skip to content

Study · Not a test of the peptide alone · 2023

1 result

Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells Attenuates Heat Stress-Induced Exacerbation of Neuropathology Following Brain Blast Injury.

Muresanu DF, Sharma A, Tian ZR, Lafuente JV, Nozari A, Feng L, Buzoianu AD, Wiklund L, Sharma HS

Advances in neurobiology1 Jan 2023

PMID37480463 (opens in a new tab)DOI10.1007/978-3-031-32997-5_6 (opens in a new tab)PepBankPUB-37480463
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 01AnimalNot a test of Cerebrolysin aloneOther designEfficacy outcome

    In experimental brain blast injury, combined nanowired mesenchymal stem cells and Cerebrolysin attenuated exacerbation in a hot environment.

    In plain wordsIn experimental brain injury, combined nanowired stem cells and Cerebrolysin reduced exacerbation in a hot environment.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseExacerbated brain blast injury
    Study

    n: not reported in source

    brain blast injury in a hot environment
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    Our observations are the first to show that combined nanowired delivery of mesenchymal stem cells (MSCs) and cerebrolysin significantly attenuated exacerbation of bBI in hot environment and induced superior neuroprotection, not reported earlier.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.